microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma

被引:52
作者
Zhou, Changchun [2 ,3 ]
Liu, Jibing [4 ]
Li, Yang [5 ]
Liu, Li [1 ,2 ]
Zhang, Xiaojiao [1 ,2 ]
Ma, Cheng-Yuan [6 ]
Hua, Shu-Cheng [5 ]
Yang, Ming [1 ,2 ]
Yuan, Qipeng [1 ,2 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China
[2] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing, Peoples R China
[3] Shandong Canc Hosp, Clin Lab, Jinan, Shandong, Peoples R China
[4] Shandong Canc Hosp, Dept Intervent Surg, Jinan, Shandong, Peoples R China
[5] Jilin Univ, Hosp 1, Dept Respirat, Changchun 130023, Jilin Province, Peoples R China
[6] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Jilin Province, Peoples R China
关键词
microRNA-1274a; Sorafenib; Hepatocellular cancer; ADAM9; INDUCED APOPTOSIS; BREAST-CANCER; EXPRESSION; CELLS;
D O I
10.1016/j.febslet.2011.04.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with poor prognosis. Sorafenib, a multikinase inhibitor, has been widely used to treat patients with advanced HCC in clinic. We postulated that microRNAs (miRNA) might be involved in HCC target-chemotherapy with sorafenib. MiRNA profile of HepG2 was evaluated after cells were treated with vehicle or sorafenib and alterations in miRNA expression occurred with 14 miRNAs. MiR-1274a, which is up-regulated by sorafenib, could significantly repress expression of ADAM9, a protease that is involved in sorafenib target-therapy of HCC, in HCC cells. Taken together, our data emphasizes a new miRNA-based mechanism of sorafenib antitumor therapy. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1828 / 1834
页数:7
相关论文
共 32 条
[1]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[2]   New therapies for hepatocellular carcinoma [J].
Avila, M. A. ;
Berasain, C. ;
Sangro, B. ;
Prieto, J. .
ONCOGENE, 2006, 25 (27) :3866-3884
[3]   MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib [J].
Bai, Shoumei ;
Nasser, Mohd W. ;
Wang, Bo ;
Hsu, Shu-Hao ;
Datta, Jharna ;
Kutay, Huban ;
Yadav, Arti ;
Nuovo, Gerard ;
Kumar, Pawan ;
Ghoshal, Kalpana .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (46) :32015-32027
[4]   Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes [J].
Braconi, Chiara ;
Valeri, Nicola ;
Gasparini, Pierluigi ;
Huang, Nianyuan ;
Taccioli, Cristian ;
Nuovo, Gerard ;
Suzuki, Tetsuro ;
Croce, Carlo Maria ;
Patel, Tushar .
CLINICAL CANCER RESEARCH, 2010, 16 (03) :957-966
[5]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[6]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[7]   BAY 43-9006 inhibition of oncogenic RET mutants [J].
Carlomagno, F ;
Anaganti, S ;
Guida, T ;
Salvatore, G ;
Troncone, G ;
Wilhelm, SM ;
Santoro, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05) :326-334
[8]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
[9]  
de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
[10]   Proteolytic processing of Delta-like 1 by ADAM proteases [J].
Dyczynska, Emilia ;
Sun, Danqiong ;
Yi, Haiqing ;
Sehara-Fujisawa, Atsuko ;
Blobel, Carl P. ;
Zolkiewska, Anna .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) :436-444